Fig. 9From: Dual effect of DLBCL-derived EXOs in lymphoma to improve DC vaccine efficacy in vitro while favor tumorgenesis in vivoSchematic representation of the therapy targeting exosomes-derived from DLBCL. TEXs, Exosomes derived from tumor cells; Chemo, Chemotherapy; MRD, Minimal residual disease; PBMNCs, Human peripheral blood mononuclear cells; DC, Dendritic cell; IDC, Immature dendritic cell; mDC, Mature dendritic cell; DCtex vaccine, TEXs- pulsed DC vaccineBack to article page